Patient Management

2074 questions

Question 1221Question →

Pulmonary embolism (PE) is a potentially life-threatening condition, but its diagnostic workup must be tailored to patient stability, pre-test probability, and comorbidities to avoid unnecessary risk. Match each patient presentation with the most appropriate guideline-indicated next diagnostic step in their evaluation.

Click a left item, then click its matching right item

Items

A 65-year-old man with high clinical probability of PE (Wells score 6.5) and an estimated glomerular filtration rate of 22 mL/min/1.73 m2
A 45-year-old woman with suspected massive PE presenting with a blood pressure of 70/40 mmHg on vasopressors, deemed too hemodynamically unstable for transport
A 32-year-old pregnant woman at 12 weeks gestation presenting with acute-onset dyspnea, pleuritic chest pain, and unilateral right calf swelling
A 28-year-old man with mild pleuritic chest pain, normal vital signs, no signs of deep vein thrombosis, and low clinical probability of PE (Wells score 1.0)

Matches

Show answer & explanation

Answer

The correct pairings align the patient's specific clinical constraints (severe renal failure, hemodynamic instability, pregnancy with DVT signs, and low pre-test probability) with their corresponding safe and effective diagnostic modality.
The correct matches follow guideline-directed diagnostic pathways for pulmonary embolism: D-dimer is used exclusively to rule out PE in low-probability patients; bedside echocardiography evaluates for right heart strain in hemodynamically unstable patients who cannot safely travel; V/Q scanning replaces CTPA in patients with severe renal dysfunction; and lower extremity compression ultrasonography is the first step in pregnant patients presenting with leg symptoms to avoid unnecessary radiation.

Step-by-Step Solution

1
Evaluate the pre-test probability and hemodynamic stability of each patient.
Identified low probability in the 28-year-old, severe hemodynamic instability in the 45-year-old, and high clinical probability in the remaining two patients.
Hemodynamic stability determines if the patient can undergo transport for advanced imaging, while clinical probability dictates if a non-invasive rule-out test is appropriate.
2
Identify specific physiological contraindications to standard computed tomography pulmonary angiography (CTPA).
The 65-year-old has severe renal impairment, and the 32-year-old is pregnant and presenting with concurrent signs of a deep vein thrombosis.
CTPA contrast can precipitate acute kidney injury in advanced chronic kidney disease, and radiation exposure should be minimized in pregnancy if alternative diagnostic pathways (like scanning the symptomatic leg) exist.
3
Match the optimal alternative test to each clinical constraint.
Assigned V/Q scan to the patient with renal failure, bedside echocardiography to the unstable patient, lower extremity ultrasound to the pregnant patient, and D-dimer to the low-probability patient.
These pairings adhere strictly to established clinical guidelines for the workup of pulmonary embolism.

Key Concept

Diagnostic algorithms for suspected pulmonary embolism must be adapted sequentially based on hemodynamic stability, pre-test probability (e.g., Wells criteria), renal function, and pregnancy status.
Question 1222Question →

A 64-year-old man presents to the clinic for an initial visit to establish primary care. He has a history of chronic obstructive pulmonary disease and a 40 pack-year smoking history. Two weeks ago, he was evaluated at an urgent care center for an exacerbation of his chronic cough, which was successfully treated with a short course of oral corticosteroids. A chest radiograph performed during that visit revealed a 14-millimeter, noncalcified, peripheral nodule in the right upper lobe. Medical records indicate that a previous chest radiograph obtained four years ago showed no evidence of this nodule. The patient currently feels well and reports his cough has returned to baseline. Vital signs are within normal limits. Physical examination reveals distant breath sounds and mild end-expiratory wheezing, but is otherwise unremarkable.

Which of the following is the most appropriate next step in the diagnostic evaluation of this patient's lung nodule?

Show answer & explanation

Answer: Computed tomography of the chest

Answer

The most appropriate next step is to perform a computed tomography (CT) of the chest.
The correct sequence for evaluating a newly discovered solitary pulmonary nodule begins with comparing the current radiograph to previous imaging. Since this has already been done and confirms the nodule is new, the immediate next step is to obtain a non-contrast, thin-slice computed tomography (CT) scan of the chest. A CT scan provides critical anatomical details—precise size, margins (e.g., smooth vs. spiculated), and internal density (e.g., benign calcification patterns)—that a plain radiograph cannot reliably demonstrate. These features are strictly required to stratify the patient's risk of malignancy and to guide subsequent management, which might involve a PET scan, tissue sampling, or interval CT surveillance.

Step-by-Step Solution

1
Identify the primary clinical problem from the vignette.
The patient has a newly identified, 14-millimeter solitary pulmonary nodule on a chest radiograph.
Establishing the primary problem directs the application of the correct diagnostic algorithm.
2
Assess the patient's risk factors and the chronicity of the finding.
The patient is high-risk (age >60, 40 pack-year smoking history), and previous imaging confirms the nodule is new within the last four years.
Prior imaging is the first step in evaluating a pulmonary nodule; a stable nodule for >2 years typically requires no further workup, whereas a new nodule requires immediate further characterization.
3
Determine the next sequential diagnostic step according to established guidelines for a new pulmonary nodule.
A thin-slice, non-contrast CT scan of the chest is indicated.
Chest radiography lacks the resolution to accurately assess the size, margins, and internal characteristics (like specific calcification patterns or fat) of a nodule. CT is required to inform the next steps, which may include PET, biopsy, or surveillance.

Key Concept

The initial evaluation of a newly identified solitary pulmonary nodule on a chest radiograph requires comparison with old imaging; if the nodule is new or changing, the mandatory next step in the diagnostic sequence is a dedicated non-contrast chest CT.
Question 1223Question →

A 6565-year-old man presents to the urgent care clinic with a 11-day history of excruciating pain in his right big toe. The pain awoke him from sleep and is so severe that he cannot tolerate the weight of his bedsheets. His medical history is significant for ischemic cardiomyopathy with a left ventricular ejection fraction of 25%25\%, chronic kidney disease stage 4, type 2 diabetes mellitus, and hyperlipidemia. His current medications include carvedilol, sacubitril-valsartan, empagliflozin, furosemide, and atorvastatin. Vital signs show a blood pressure of 118/76118/76 mm Hg, heart rate of 7272/min, and temperature of 37.1∘37.1^\circ C. Physical examination reveals a markedly erythematous, swollen, and exquisitely tender right first metatarsophalangeal joint. The remainder of the joint examination is unremarkable. Laboratory studies from one week ago showed a serum creatinine of 2.62.6 mg/dL (estimated glomerular filtration rate 2424 mL/min/1.731.73 m 2^2) and a hemoglobin A1c of 7.8%7.8\%. Joint aspiration is deferred as the clinical presentation is highly classic for podagra. Which of the following is the most appropriate initial pharmacologic therapy for this patient's acute joint condition?

Show answer & explanation

Answer: Intra-articular methylprednisolone

Answer

Intra-articular methylprednisolone
The correct answer is intra-articular methylprednisolone. This patient has classic acute gouty arthritis (podagra). In a patient with multiple severe comorbidities including heart failure with reduced ejection fraction, stage 4 chronic kidney disease, and diabetes mellitus, systemic therapies pose significant risks. Nonsteroidal anti-inflammatory drugs (NSAIDs) are contraindicated due to heart failure and severe renal impairment. Colchicine is associated with severe neuromyopathy in advanced renal failure, a risk that is amplified by concomitant statin use. Systemic glucocorticoids could worsen both heart failure (through fluid retention) and diabetes (through hyperglycemia). Therefore, an intra-articular glucocorticoid injection provides rapid, effective, localized relief for monoarticular disease while safely circumventing the patient's systemic contraindications.

Step-by-Step Solution

1
Diagnose the acute condition.
The patient is experiencing an acute gout flare (podagra) of the first metatarsophalangeal joint.
The sudden onset of severe nocturnal pain, erythema, and exquisite tenderness at the first MTP joint is the classic presentation of acute gout.
2
Evaluate the patient's comorbidities and current medications.
The patient has HFrEF, Stage 4 CKD, Type 2 Diabetes, and takes a statin.
Comorbidities dictate which standard acute gout treatments (NSAIDs, colchicine, systemic steroids) are safe to use.
3
Eliminate contraindicated or high-risk systemic therapies.
NSAIDs and colchicine are ruled out. Systemic glucocorticoids are less desirable.
NSAIDs worsen CKD and HF. Colchicine causes toxicity in CKD, worsened by statins. Systemic steroids can exacerbate HF (fluid retention) and diabetes (hyperglycemia).
4
Select the safest effective intervention.
Intra-articular methylprednisolone is chosen.
For monoarticular gout, intra-articular glucocorticoids deliver potent anti-inflammatory effects directly to the joint while minimizing systemic absorption and avoiding systemic contraindications.

Key Concept

Management of acute gout flares in patients with multiple medical comorbidities that contraindicate standard systemic therapies.
Question 1224Question →

A 52-year-old man is brought to the emergency department by coworkers after collapsing in an agricultural field where he was spraying pesticides. On arrival, he is confused, agitated, and incontinent of urine and feces. Physical examination reveals profuse diaphoresis, copious salivation, and diffuse wheezing on lung auscultation. His pupils are 1 mm bilaterally. Vital signs show a temperature of 37.1 C (98.8 F), heart rate of 42/min, blood pressure of 85/55 mmHg, respiratory rate of 28/min, and oxygen saturation of 87% on room air. He is actively coughing up large amounts of clear, frothy secretions. Which of the following are the most appropriate simultaneous initial steps in the management of this patient? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Administration of intravenous atropine; Complete removal of the patient's clothing and dermal decontamination

Answer

The most appropriate simultaneous initial steps are the administration of intravenous atropine and the complete removal of the patient's clothing with dermal decontamination.
This patient presents with a classic cholinergic toxidrome (diaphoresis, salivation, miosis, bradycardia, wheezing, incontinence) due to occupational organophosphate pesticide exposure. Organophosphates irreversibly inhibit acetylcholinesterase, leading to massive acetylcholine accumulation at muscarinic and nicotinic receptors. The immediate life-threats are respiratory failure (from profound bronchorrhea and bronchospasm) and hemodynamic collapse (from severe bradycardia). The most urgent initial stabilization step is to simultaneously administer intravenous atropine to competitively antagonize muscarinic receptors (improving heart rate and drying airway secretions) and to perform complete dermal decontamination by removing all clothing and thoroughly washing the patient. Decontamination is critical in triage to stop ongoing transdermal absorption and prevent the poisoning of healthcare workers.

Step-by-Step Solution

1
Identify the toxidrome based on the clinical presentation and context.
The patient's agricultural work, bradycardia, miosis, salivation, wheezing, and incontinence indicate a cholinergic crisis, most likely from organophosphate poisoning.
Recognizing the DUMBELS mnemonic (Diaphoresis/Diarrhea, Urination, Miosis, Bradycardia/Bronchorrhea/Bronchospasm, Emesis, Lacrimation, Salivation) establishes the diagnosis.
2
Determine the most critical, immediate life-threats.
The patient is in respiratory distress due to severe bronchorrhea and bronchospasm, complicated by cardiogenic shock from severe bradycardia.
Airway compromise from excessive secretions and hemodynamic instability require immediate pharmacological reversal of muscarinic effects.
3
Select the appropriate simultaneous interventions for initial stabilization.
Administer high-dose intravenous atropine while simultaneously removing all of the patient's clothing and washing the skin.
Atropine dries secretions and improves heart rate. Dermal decontamination stops ongoing absorption and protects emergency department staff from secondary exposure.

Key Concept

Initial stabilization of severe organophosphate toxicity requires immediate administration of atropine to manage life-threatening muscarinic symptoms (bronchorrhea, bronchospasm, bradycardia) alongside concurrent dermal decontamination to halt further absorption.
Question 1225Question →

Match each clinical presentation with the most appropriate next diagnostic test.

Click a left item, then click its matching right item

Items

28-year-old woman at 14 weeks gestation with acute dyspnea; leg ultrasound is negative for deep vein thrombosis and chest radiograph is unremarkable.
62-year-old man with tearing back pain and asymmetric radial pulses; serum creatinine is 3.1 mg/dL and he is hemodynamically stable.
65-year-old woman with exertional chest pain requiring risk stratification; baseline ECG shows a left bundle branch block and severe osteoarthritis precludes exercise.
35-year-old man with fleeting chest pain; vital signs are normal, no hemoptysis is present, and his Wells score is 1.
72-year-old man with a pulsatile abdominal mass noted on routine physical examination; he is completely asymptomatic and hemodynamically stable.

Matches

Show answer & explanation

Answer

The correct matches align each specific clinical scenario with its guideline-directed diagnostic modality: the pregnant patient with a normal chest X-ray requires a V/Q scan, the patient with suspected aortic dissection and renal failure requires a TEE, the patient with LBBB requires vasodilator myocardial perfusion imaging, the low-probability PE patient requires a D-dimer assay, and the asymptomatic patient with a pulsatile abdominal mass requires abdominal duplex ultrasonography.
Each diagnostic test is specifically indicated to circumvent contraindications or optimize predictive value: V/Q limits breast radiation in pregnancy, TEE avoids nephrotoxic contrast in renal failure, vasodilators prevent LBBB-induced septal artifacts, D-dimer prevents over-testing in low-risk patients, and ultrasound provides safe screening for asymptomatic abdominal masses.

Step-by-Step Solution

1
Evaluate the clinical presentation of the 28-year-old pregnant patient.
Suspected pulmonary embolism with negative lower extremity ultrasound and normal chest X-ray.
Determines the next safest imaging modality; V/Q scan is indicated as it reduces maternal breast radiation compared to CTPA, and D-dimer is physiologically elevated in pregnancy.
2
Assess the 62-year-old man with tearing back pain.
Suspected aortic dissection in the setting of severe acute or chronic kidney injury.
To avoid contrast-induced nephropathy, TEE is chosen over CTA for rapid, accurate diagnosis of a dissection.
3
Analyze the 65-year-old woman with exertional chest pain.
Needs risk stratification but has a left bundle branch block and cannot exercise.
LBBB precludes exercise or dobutamine stress echocardiography due to septal motion artifact, requiring a vasodilator myocardial perfusion scan.
4
Review the 35-year-old man with fleeting chest pain.
Low pre-test probability for pulmonary embolism.
According to guidelines, a D-dimer test is the most appropriate initial step to rule out PE and avoid unnecessary imaging radiation.
5
Evaluate the 72-year-old man with a pulsatile abdominal mass.
Suspected abdominal aortic aneurysm in a stable, asymptomatic patient.
Abdominal duplex ultrasound is the most cost-effective and non-invasive initial test to establish the diagnosis and quantify aneurysm diameter.

Key Concept

Guideline-directed sequencing of diagnostic tests based on patient-specific contraindications, such as pregnancy, renal failure, and baseline electrocardiographic abnormalities.
Estimated Time:2m 0s
Question 1226Question →

A 68-year-old woman with highly symptomatic paroxysmal atrial fibrillation is admitted to the cardiology service for initiation of dofetilide therapy. Her past medical history is significant for hypertension and heart failure with preserved ejection fraction. Her home medications include metoprolol succinate, losartan, and apixaban. Which of the following parameters must be strictly monitored during the initial inpatient phase of therapy with this medication? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Continuous electrocardiography; Serum creatinine; Serum potassium and magnesium

Answer

The correct parameters to monitor are continuous electrocardiography, serum creatinine, and serum potassium and magnesium.
Dofetilide is a potent Class III antiarrhythmic with a narrow therapeutic index and a high risk of causing drug-induced Long QT syndrome and Torsades de Pointes. To mitigate this risk, strict regulatory and clinical protocols mandate that initiation occur in a monitored inpatient setting for at least 72 hours (or 5 doses). During this time, continuous electrocardiography (telemetry) is required to monitor the QT c_c interval after each dose. Because the drug is primarily cleared by the kidneys, serum creatinine must be drawn to calculate creatinine clearance, as dosing is highly dependent on renal function. Furthermore, serum potassium and magnesium must be monitored and aggressively repleted, as hypokalemia and hypomagnesemia independently prolong the QT interval and synergistically increase the risk of fatal arrhythmias.

Step-by-Step Solution

1
Identify the pharmacologic properties of the newly initiated medication.
Dofetilide is a Class III antiarrhythmic agent that prolongs the cardiac action potential and the QT interval by blocking IKrI_{Kr} potassium channels.
Understanding the drug's mechanism highlights its primary adverse effect: dose-dependent QT prolongation leading to Torsades de Pointes.
2
Determine the clearance mechanism of the drug.
Dofetilide is primarily excreted unchanged by the kidneys.
Small fluctuations in renal function can cause drug accumulation and dangerous toxicity, necessitating strict dose adjustments based on creatinine clearance.
3
Apply standard safety guidelines for drug initiation.
Guidelines mandate a 72-hour inpatient admission for continuous ECG telemetry, serial renal function checks (serum creatinine), and electrolyte monitoring (potassium and magnesium).
This highly controlled environment ensures the QT interval remains within safe limits and arrhythmias are immediately treated if they occur.

Key Concept

Initiation of dofetilide requires mandatory inpatient admission for continuous electrocardiographic monitoring, renal function assessment, and electrolyte optimization due to the high risk of life-threatening QT prolongation.
Question 1227Question →

A 7272-year-old woman is brought to the emergency department by her family due to a 33-day history of worsening abdominal distension, severe crampy abdominal pain, and an inability to pass flatus or stool. Her past medical history is significant for hypertension and osteoarthritis. Her temperature is 37.4∘C37.4^{\circ}\text{C} (99.3∘F99.3^{\circ}\text{F}), blood pressure is 135/85 mmHg135/85\text{ mmHg}, pulse is 98/min98/\text{min}, and respiratory rate is 16/min16/\text{min}. Physical examination reveals a markedly distended, tympanic abdomen with diffuse mild tenderness but no rebound or guarding. Computed tomography (CT) of the abdomen and pelvis with intravenous contrast reveals an obstructing mass in the sigmoid colon with severe proximal large bowel dilation. The cecum measures 11.5 cm11.5\text{ cm} in diameter. There is no free intraperitoneal air. Intravenous fluids and nasogastric decompression are initiated. Which of the following are appropriate next steps in the procedural management of this patient? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Endoscopic placement of a self-expanding metal stent; Emergent laparotomy with bowel resection and proximal diversion

Answer

The correct appropriate next steps are endoscopic placement of a self-expanding metal stent and emergent laparotomy with bowel resection and proximal diversion.
The correct procedural interventions are endoscopic placement of a self-expanding metal stent and emergent laparotomy with bowel resection. This patient presents with a malignant left-sided large bowel obstruction and a cecal diameter of 11.5 cm11.5\text{ cm}. According to Laplace's law, the cecum experiences the greatest wall tension and is at the highest risk of perforation when distended. A diameter exceeding 10 cm10\text{ cm} indicates impending rupture and requires urgent procedural decompression. This can be achieved through immediate surgical intervention (such as a Hartmann procedure) or through the placement of an endoscopic self-expanding metal stent (SEMS), which decompresses the colon and serves as a 'bridge' to an elective, safer, single-stage surgical resection.

Step-by-Step Solution

1
Analyze the clinical presentation and diagnostic findings.
The patient has a symptomatic large bowel obstruction caused by a sigmoid mass, with a cecal diameter of 11.5 cm11.5\text{ cm}.
Identifying the severity of the obstruction is required to dictate the urgency of procedural intervention.
2
Evaluate the risk of complications based on imaging.
A cecum measuring greater than 10 cm10\text{ cm} indicates impending perforation, often due to a closed-loop obstruction involving a competent ileocecal valve.
Impending perforation necessitates immediate procedural decompression rather than observation or medical management alone.
3
Select the appropriate procedural interventions for acute decompression.
Both endoscopic stenting (as a bridge to surgery) and emergent surgical resection (with diversion) are valid, definitive means to urgently decompress the colon and prevent perforation.
These interventions directly resolve the mechanical obstruction safely, whereas oral preparations and barium are contraindicated.

Key Concept

Management of acute large bowel obstruction with impending cecal perforation requires urgent procedural decompression via either endoscopic stenting or emergent surgical resection.
Question 1228Question →

During a routine follow-up visit, a retired construction worker with a 15-year history of poorly controlled type 2 diabetes mellitus asks the physician to evaluate a wound on the bottom of his right foot. He noticed a foul-smelling discharge on his sock earlier this week but denies any pain, fever, or chills. Vital signs are within normal limits. Examination of the right plantar aspect reveals a 3 cm by 2 cm deep ulceration under the first metatarsal head. The ulcer is surrounded by a 2-cm rim of erythema and warmth. Dorsalis pedis and posterior tibial pulses are 2+ bilaterally. Probing the base of the ulcer with a sterile blunt instrument reveals a hard, gritty surface. Which of the following diagnostic steps are indicated as the most appropriate initial evaluation for this patient's current condition? (Select 2)

Select all that apply

Show answer & explanation

Answer: Plain radiography of the affected foot; Serum erythrocyte sedimentation rate and C-reactive protein levels

Answer

The correct initial diagnostic steps are plain radiography of the affected foot and measurement of serum erythrocyte sedimentation rate and C-reactive protein levels.
Plain radiography is the mandatory first-line imaging modality for suspected osteomyelitis to detect gross bone abnormalities, foreign bodies, or soft tissue gas, and to establish a baseline. Concurrently, serum inflammatory markers (ESR and CRP) are indicated to assess the severity of systemic inflammation and provide a benchmark for monitoring the patient's response to targeted therapy. A positive probe-to-bone test is highly specific for osteomyelitis, meaning the immediate diagnostic goal is baseline assessment rather than rushing to advanced, expensive imaging or collecting low-fidelity superficial cultures.

Step-by-Step Solution

1
Recognize the clinical presentation of a deep diabetic foot ulcer with a positive probe-to-bone test.
High clinical suspicion for contiguous osteomyelitis.
The probe-to-bone test (feeling a hard, gritty surface) has a high positive predictive value for osteomyelitis in the setting of an infected diabetic foot ulcer.
2
Determine the first-line imaging modality for suspected osteomyelitis.
Select plain radiography.
Plain films are the standard initial imaging test to assess for cortical destruction, periosteal reaction, and tissue gas, and they provide a baseline for future comparison.
3
Determine the appropriate baseline laboratory workup.
Select inflammatory markers (erythrocyte sedimentation rate and C-reactive protein).
These markers help establish the baseline level of inflammation, support the clinical diagnosis, and are utilized to monitor the response to future antibiotic or surgical therapy.
4
Exclude inappropriate initial tests.
Defer advanced imaging and avoid superficial cultures.
Advanced imaging is reserved for cases with negative plain films or for presurgical planning. Superficial swabs only identify colonizing skin flora, not the deep pathogens responsible for osteomyelitis.

Key Concept

In the initial evaluation of suspected diabetic foot osteomyelitis, the most appropriate diagnostic sequence begins with plain radiography and baseline inflammatory markers, avoiding premature advanced imaging and misleading superficial swab cultures.
Question 1229Question →

An emergency department evaluates a 68-year-old man who reports progressive generalized weakness and perioral numbness over the past 48 hours. He recently began taking lisinopril and spironolactone for newly diagnosed heart failure with reduced ejection fraction. His blood pressure is 118/72 mm Hg, heart rate is 54/min, and respiratory rate is 16/min. He continues to produce adequate urine.

Laboratory studies show:
Serum sodium: 136 mEq/L
Serum potassium: 7.8 mEq/L
Serum chloride: 104 mEq/L
Serum bicarbonate: 18 mEq/L
Blood urea nitrogen: 48 mg/dL
Serum creatinine: 2.9 mg/dL (baseline 1.8 mg/dL)

An electrocardiogram demonstrates absent P waves, widening of the QRS complex, and tall, peaked T waves.

Arrange the following pharmacologic interventions in the most appropriate chronological sequence for the acute management of this patient's condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for managing severe hyperkalemia with electrocardiogram changes is: 1) Intravenous calcium gluconate, 2) Intravenous regular insulin with 50% dextrose, 3) Intravenous furosemide, and 4) Oral patiromer.
The fundamental paradigm for treating life-threatening hyperkalemia is 'Stabilize, Shift, Excrete'. Intravenous calcium gluconate must be given first to stabilize the cardiac myocyte membrane and prevent lethal arrhythmias. This is followed by rapid intracellular shifting agents (insulin with dextrose) which take effect in 15-30 minutes. Finally, total body potassium is reduced through renal excretion (furosemide) and gastrointestinal binding (patiromer), which take hours to days to become fully effective.

Step-by-Step Solution

1
Assess the electrocardiogram and serum potassium level.
The patient has severe hyperkalemia (7.8 mEq/L) with critical electrocardiogram changes indicating impending fatal arrhythmia (widened QRS, absent P waves).
Electrocardiogram changes dictate the immediate need for cardiac membrane stabilization.
2
Administer an agent for immediate cardiac membrane stabilization.
Intravenous calcium gluconate is given first.
Calcium antagonizes the membrane effects of potassium and protects the heart, acting within minutes.
3
Administer agents to rapidly shift potassium intracellularly.
Intravenous regular insulin with dextrose is given next.
This temporarily lowers serum potassium levels while definitive removal strategies take effect.
4
Initiate therapies to permanently remove potassium from the body.
Intravenous furosemide is given to increase renal excretion, followed by oral patiromer for gastrointestinal elimination.
Loop diuretics work over hours, while gastrointestinal binders take hours to days, making them the final steps in acute stabilization.

Key Concept

The management of severe hyperkalemia follows a strict sequential framework: (1) stabilize the cardiac membrane with intravenous calcium, (2) shift potassium intracellularly with insulin/glucose or beta-agonists, and (3) excrete potassium from the body using diuretics, gastrointestinal binders, or dialysis.
Question 1230Question →

A 79-year-old man residing in a skilled nursing facility is brought to the emergency department due to progressively worsening abdominal distension, severe pain, and failure to pass stool or flatus over the past 48 hours. His medical history includes Parkinson disease, chronic constipation, and mild cognitive impairment. His temperature is 38.6∘C38.6^\circ\text{C}, blood pressure is 86/54 mm Hg86/54\text{ mm Hg}, heart rate is 126/min126\text{/min}, and respiratory rate is 24/min24\text{/min}. He appears distressed and diaphoretic. Abdominal examination reveals profound distension with diffuse rigidity, marked tenderness to palpation, and rebound tenderness. Bowel sounds are absent. An upright plain radiograph of the abdomen displays a massive, dilated, inverted U-shaped loop of large bowel extending from the pelvis toward the right upper quadrant, with no free air under the diaphragm. Laboratory studies demonstrate a leukocyte count of 18,500/μL18,500/\mu\text{L} and serum lactate of 5.1 mmol/L5.1\text{ mmol/L}. Following initial intravenous fluid resuscitation and broad-spectrum antibiotic administration, which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Exploratory laparotomy with bowel resection

Answer

Exploratory laparotomy with bowel resection
This patient has a sigmoid volvulus that has progressed to bowel ischemia and peritonitis. This is evidenced by his systemic inflammatory response (fever, leukocytosis), hemodynamic instability (hypotension, tachycardia), tissue hypoperfusion (elevated lactate), and peritonitis (rigidity, rebound tenderness). While uncomplicated sigmoid volvulus is typically managed with therapeutic flexible sigmoidoscopy to untwist the bowel, the presence of peritonitis or gangrene is an absolute indication for emergent exploratory laparotomy. Attempting endoscopic detorsion in an ischemic colon risks gross perforation.

Step-by-Step Solution

1
Analyze the patient's risk factors and radiographic findings.
The patient is an elderly male with Parkinson disease and chronic constipation presenting with a classic 'inverted U-shaped' (coffee bean) loop of bowel on radiograph, diagnosing a sigmoid volvulus.
Identifying the primary pathology is required before determining the appropriate intervention.
2
Evaluate the patient's clinical stability and physical examination findings.
The patient has fever, hypotension, tachycardia, leukocytosis, elevated lactate, and diffuse abdominal rigidity with rebound tenderness.
These findings indicate that the volvulus has progressed to strangulation, bowel ischemia, and peritonitis.
3
Select the appropriate procedural intervention based on the clinical status.
Because signs of bowel necrosis and peritonitis are present, non-operative measures are contraindicated. Emergent exploratory laparotomy with bowel resection is required.
First-line endoscopic management is reserved solely for patients without signs of ischemia or peritonitis.

Key Concept

Patients with sigmoid volvulus who exhibit signs of peritonitis, bowel ischemia, or perforation require immediate surgical exploration and resection rather than endoscopic detorsion.
Question 1231Question →

A 67-year-old woman with end-stage renal disease on hemodialysis is admitted for a severe diabetic foot infection. She is treated with intravenous vancomycin and prophylactic subcutaneous unfractionated heparin. On hospital day 7, she develops sudden-onset dyspnea and pleuritic chest pain. Vital signs show a heart rate of 112/min, blood pressure of 130/80 mmHg, and oxygen saturation of 89% on room air. Computed tomography pulmonary angiography confirms a new segmental pulmonary embolism. Laboratory studies reveal a platelet count of 65,000/mm³, which has fallen from a baseline of 240,000/mm³ on admission. The 4Ts score is calculated as 7, indicating a high probability of heparin-induced thrombocytopenia (HIT). The clinical team decides to manage her acute thrombosis and bridge her to long-term oral anticoagulation with a vitamin K antagonist.

Arrange the following pharmacologic orders in the strict chronological sequence required to safely manage this patient's coagulopathy from the acute phase through the transition to outpatient therapy.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: 1) Discontinue subcutaneous unfractionated heparin, 2) Initiate continuous intravenous argatroban infusion, 3) Initiate oral warfarin therapy (upon platelet recovery), and 4) Discontinue intravenous argatroban infusion (after therapeutic overlap).
The safe management of Heparin-Induced Thrombocytopenia (HIT) requires a rigid chronological protocol to prevent catastrophic thrombotic complications. The offending agent (heparin) must be stopped immediately. Because the patient has an active pulmonary embolism and a highly prothrombotic state, an alternative non-heparin anticoagulant must be started concurrently. Given her end-stage renal disease, argatroban is the anticoagulant of choice due to its hepatic clearance. Transitioning to outpatient warfarin therapy requires strict timing: it must NEVER be started while the patient is actively thrombocytopenic due to the risk of venous limb gangrene from precipitous Protein C depletion. Therefore, warfarin is only initiated once the platelet count recovers to >150,000/mm³. Finally, because warfarin takes days to achieve full antithrombotic efficacy, the argatroban infusion must overlap with warfarin for a minimum of 5 days and until the INR is therapeutic for two consecutive days before it can be discontinued.

Step-by-Step Solution

1
Discontinue subcutaneous unfractionated heparin
Halts the administration of the inciting antigen.
Continuing any form of heparin fuels the formation of IgG antibodies against the heparin-platelet factor 4 (PF4) complex, driving further platelet activation and thrombosis.
2
Initiate continuous intravenous argatroban infusion
Provides immediate, safe therapeutic anticoagulation.
Patients with HIT and thrombosis require immediate non-heparin anticoagulation. Argatroban (a direct thrombin inhibitor) is chosen here because its hepatic clearance makes it safe for a patient with end-stage renal disease, unlike bivalirudin or fondaparinux.
3
Initiate oral warfarin therapy
Begins the transition to long-term oral anticoagulation.
Warfarin initiation is strictly contraindicated during the acute thrombocytopenic phase of HIT. It must be delayed until platelets recover to at least 150,000/mm³ to prevent venous limb gangrene caused by rapid protein C depletion.
4
Discontinue intravenous argatroban infusion
Completes the transition to monotherapy with a vitamin K antagonist.
Argatroban can only be discontinued after an adequate overlap with warfarin (minimum of 5 days) AND once the INR has been therapeutic (typically 2.0-3.0) for at least 48 hours, ensuring full suppression of vitamin K-dependent clotting factors.

Key Concept

Pharmacologic bridging sequence for Heparin-Induced Thrombocytopenia (HIT) transitioning to Warfarin
Estimated Time:2m 0s
Question 1232Question →

A 19-year-old male university student is transported to the trauma bay after falling approximately 15 feet from a balcony. Paramedics note that he was initially conversing and complaining of a severe headache, but his mental status rapidly deteriorated en route. Upon arrival, he is deeply obtunded and withdraws only to painful stimuli. Vital signs are temperature 37.0∘C37.0^\circ\text{C} (98.6∘F98.6^\circ\text{F}), blood pressure 185/105 mmHg185/105\text{ mmHg}, pulse 42/min42/\text{min}, and respirations 6/min6/\text{min} and irregular. Physical examination reveals a right pupil that is 7 mm7\text{ mm} and unreactive to light; the left pupil is 3 mm3\text{ mm} and briskly reactive. Intravenous access was established in the field. Arrange the following patient management steps in the most appropriate chronological order.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The sequence must strictly follow the Advanced Trauma Life Support (ATLS) protocol: first secure the airway, second medically temporize the active brain herniation, third obtain diagnostic neuroimaging, and fourth proceed to definitive surgical intervention.
The sequence aligns with standard trauma resuscitation guidelines. Airway protection is always the initial step for a patient lacking airway reflexes or adequate ventilation. Subsequently, the acute clinical presentation of uncal herniation (asymmetric pupils and Cushing reflex) demands immediate empiric treatment with osmotic agents to lower intracranial pressure. Only after these immediate stabilizing measures should the patient be transported for diagnostic imaging (CT head) to delineate the anatomy of the injury, which then guides the definitive neurosurgical intervention.

Step-by-Step Solution

1
Assess the airway and breathing.
Patient has depressed consciousness and irregular, slow respirations.
Airway compromise is the most immediate threat to life. Endotracheal intubation must be performed first.
2
Assess circulatory and neurologic status.
Patient demonstrates Cushing's triad (hypertension, bradycardia, irregular breathing) and a unilateral fixed/dilated pupil.
These are classic signs of uncal herniation. Medical interventions to decrease intracranial pressure (osmotic agents) must be administered concurrently with or immediately following airway management.
3
Perform diagnostic evaluation.
A noncontrast CT scan of the head is obtained.
Diagnostic imaging is required to confirm the presence, type, and exact location of the hemorrhage (e.g., epidural hematoma) before surgery can be performed.
4
Provide definitive treatment.
Neurosurgical decompression in the operating room.
Medical management only temporizes herniation; surgical evacuation of the hematoma is the definitive life-saving therapy.

Key Concept

In patients with severe traumatic brain injury and active herniation, the correct sequence is securing the airway, administering empiric hyperosmolar therapy, obtaining diagnostic imaging, and performing definitive surgical decompression.
Question 1233Question →

A 48-year-old man presents to the ambulatory clinic complaining of excessive sweating, diffuse joint pain, and an increase in his shoe size over the past two years. He notes that he recently had to have his wedding ring resized because it no longer fit his finger. He has no significant past medical history and takes no medications. Vital signs show a blood pressure of 158/96 mm Hg, pulse of 76/min, and respiratory rate of 14/min. Physical examination reveals coarse facial features, a prominent forehead, and macroglossia. There is a 'doughy' consistency to the skin on his hands. Laboratory testing reveals a serum insulin-like growth factor-1 (IGF-1) concentration of 780 ng/mL (reference range: 90-250 ng/mL). Which of the following is the most appropriate next step in this patient's diagnostic workup?

Show answer & explanation

Answer: Measurement of serum growth hormone concentration following an oral glucose load

Answer

Measurement of serum growth hormone concentration following an oral glucose load
The correct sequence for diagnosing acromegaly begins with a clinical suspicion, followed by measuring serum insulin-like growth factor-1 (IGF-1) as the initial screening test. Because growth hormone (GH) is secreted in a pulsatile manner, its levels fluctuate widely, making IGF-1 (which provides a stable, integrated marker of GH activity) the preferred initial test. If the IGF-1 level is elevated, the diagnosis MUST be confirmed biochemically before proceeding to imaging. The gold standard confirmatory test is the measurement of serum GH following an oral glucose load (oral glucose tolerance test, or OGTT). Normal individuals will suppress GH to undetectable levels after glucose ingestion, whereas patients with acromegaly will exhibit non-suppressible, elevated GH levels. Only after this biochemical confirmation is achieved should anatomical imaging (MRI of the pituitary) be performed to locate the suspected somatotroph adenoma.

Step-by-Step Solution

1
Identify the suspected diagnosis based on the clinical presentation and initial laboratory findings.
The patient has classical features of acromegaly (acral enlargement, coarse facial features, hyperhidrosis) and an elevated screening IGF-1 level.
To determine the current stage in the diagnostic algorithm.
2
Determine the standard diagnostic sequence for suspected acromegaly following an abnormal initial screening test.
Biochemical confirmation is strictly required before proceeding to anatomical imaging.
To prevent false-positive diagnoses caused by incidental pituitary adenomas, which are present in up to 20% of the general population.
3
Select the appropriate confirmatory biochemical test.
The oral glucose tolerance test (OGTT) with growth hormone measurement is chosen.
In a healthy individual, a glucose load suppresses growth hormone release. In a patient with acromegaly, growth hormone remains autonomously elevated (non-suppressible), confirming the diagnosis.

Key Concept

In the diagnostic test sequencing for acromegaly, an elevated screening serum IGF-1 level must be followed by confirmatory biochemical testing with an oral glucose tolerance test (OGTT) prior to obtaining a pituitary MRI.
Question 1234Question →

A 72-year-old woman is admitted to the hospital due to progressively worsening shortness of breath, orthopnea, and lower extremity swelling over the past four days. Her medical history is significant for ischemic cardiomyopathy with a documented left ventricular ejection fraction of 25%, type 2 diabetes mellitus, and chronic kidney disease. On triage, her temperature is 37.1°C (98.8°F), blood pressure is 102/68 mm Hg, heart rate is 148/min and irregular, respiratory rate is 24/min, and oxygen saturation is 91% on room air. Physical examination reveals elevated jugular venous pressure to 11 cm H2OH_2O, bibasilar crackles extending to the mid-lung fields, and 3+ bilateral pitting edema. An electrocardiogram is obtained and demonstrates a narrow-complex, irregularly irregular tachycardia lacking distinct P waves. She is placed on supplemental oxygen and intravenous bumetanide is prescribed. Which of the following pharmacologic agents are appropriate for immediate intravenous rate control of this patient's arrhythmia? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Intravenous amiodarone; Intravenous digoxin

Answer

The correct interventions are intravenous amiodarone and intravenous digoxin.
The correct options are intravenous amiodarone and intravenous digoxin. This patient is experiencing atrial fibrillation with a rapid ventricular response, complicated by acute decompensated heart failure (ADHF) in the setting of known heart failure with reduced ejection fraction (HFrEF). The management of rapid atrial fibrillation in ADHF requires careful selection of rate-controlling agents to avoid worsening the patient's fragile hemodynamic state. Both amiodarone and digoxin effectively slow conduction through the atrioventricular (AV) node without exerting clinically significant negative inotropic effects. Consequently, they are the preferred pharmacological interventions for acute rate control in patients with left ventricular systolic dysfunction who are actively decompensated.

Step-by-Step Solution

1
Identify the primary arrhythmia.
The ECG findings of an irregularly irregular, narrow-complex tachycardia without P waves confirm the diagnosis of atrial fibrillation with rapid ventricular response.
Establishing the correct rhythm is the first step in determining the appropriate antiarrhythmic pathway.
2
Assess the patient's hemodynamic status and coexisting conditions.
The patient has a known history of heart failure with reduced ejection fraction (HFrEF) and presents with acute volume overload (elevated jugular venous pressure, crackles, edema), indicating acute decompensated heart failure.
Coexisting acute decompensated heart failure severely restricts the choice of rate-controlling medications due to the risk of cardiovascular collapse from negative inotropes.
3
Select rate-control agents lacking negative inotropic effects.
Intravenous digoxin and intravenous amiodarone are selected as they slow atrioventricular node conduction without suppressing myocardial contractility.
Standard rate-control agents (beta-blockers, non-dihydropyridine calcium channel blockers) are contraindicated in this specific clinical context.

Key Concept

In patients presenting with atrial fibrillation with rapid ventricular response in the setting of acute decompensated heart failure with reduced ejection fraction, rate control must be achieved using agents lacking negative inotropic effects, specifically intravenous digoxin or amiodarone.
Question 1235Question →

A 65-year-old man is brought to the emergency department by emergency medical services after vomiting bright red blood at home. He has a history of osteoarthritis for which he takes daily naproxen. Upon arrival, he appears pale, anxious, and diaphoretic. His temperature is 37.1°C (98.8°F), blood pressure is 92/58 mmHg, pulse is 118/min, and respiratory rate is 18/min. Physical examination reveals conjunctival pallor and mild epigastric tenderness. Digital rectal examination shows melena. Arrange the following procedural and management steps in the most appropriate chronological sequence for this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence involves initial hemodynamic stabilization with intravenous fluids, followed by acid suppression therapy, primary endoscopic diagnosis and treatment, and finally angiographic rescue therapy if endoscopy fails.
The management of acute non-variceal upper gastrointestinal bleeding follows a strict stepwise algorithmic approach to maximize patient survival and procedural success. The immediate priority is addressing hypovolemic shock through robust intravenous access and fluid resuscitation. Once resuscitation is underway, profound acid suppression with an intravenous proton pump inhibitor is initiated to promote clot stability in the acidic gastric environment. Following initial stabilization, esophagogastroduodenoscopy is the primary procedural intervention for definitive diagnosis and targeted hemostasis (e.g., thermal coagulation, clipping). Finally, if endoscopic therapy fails to control the hemorrhage, transcatheter arterial embolization by interventional radiology serves as the definitive rescue intervention.

Step-by-Step Solution

1
Secure dual large-bore intravenous access and start intravenous fluids.
Hemodynamic stabilization and restoration of intravascular volume.
Addressing hemorrhagic shock is the immediate life-saving priority before any procedural intervention is considered.
2
Administer an intravenous proton pump inhibitor.
Elevation of gastric pH above 6.0.
A neutral pH stabilizes blood clots and prevents further degradation by pepsin, optimizing conditions prior to endoscopic visualization.
3
Perform esophagogastroduodenoscopy (EGD).
Direct visualization and targeted hemostasis of the bleeding source (e.g., peptic ulcer).
Endoscopy is the standard primary procedural modality for the diagnosis and control of upper gastrointestinal bleeding.
4
Consult interventional radiology for transcatheter arterial embolization.
Angiographic control of the bleeding vessel.
This is a salvage procedural intervention explicitly reserved for refractory bleeding that fails endoscopic control.

Key Concept

The correct sequential escalation of medical and procedural interventions for acute non-variceal upper gastrointestinal hemorrhage.
Question 1236Question →

An internal medicine physician is providing follow-up care for a 61-year-old patient with nonischemic cardiomyopathy in the outpatient clinic. The patient's most recent echocardiogram demonstrates a left ventricular ejection fraction of 28%. The patient's current medication regimen consists of carvedilol, spironolactone, dapagliflozin, and sacubitril-valsartan.

On physical examination, blood pressure is 118/74 mmHg, pulse is 68/min, and respiratory rate is 14/min. Jugular venous pressure is estimated at 6 cm H2O. Lungs are clear to auscultation bilaterally, and there is no lower extremity edema. Pertinent laboratory studies reveal a serum sodium of 139 mEq/L, potassium of 4.6 mEq/L, and creatinine of 1.1 mg/dL.

During the visit, the patient expresses concern regarding a recent loss of prescription drug coverage, stating that the sacubitril-valsartan has become financially prohibitive. After discussing alternatives, the physician and patient agree to discontinue the sacubitril-valsartan and initiate oral lisinopril to maintain optimal guideline-directed medical therapy. The patient confirms taking the final dose of sacubitril-valsartan this morning at 8:00 AM.

Based on pharmacologic safety guidelines, which of the following is the most appropriate instruction for initiating lisinopril in this patient?

Show answer & explanation

Answer: Instruct the patient to take the first dose of lisinopril tomorrow evening at 8:00 PM

Answer

The most appropriate instruction is to advise the patient to take the first dose of lisinopril tomorrow evening at 8:00 PM, exactly 36 hours after the final dose of the ARNI.
The correct action is to mandate a 36-hour washout period after the last dose of an angiotensin receptor-neprilysin inhibitor (ARNI) before initiating an angiotensin-converting enzyme (ACE) inhibitor. Because both neprilysin and ACE are primarily responsible for the degradation of bradykinin, concurrent inhibition or an insufficient washout period leads to excessive bradykinin accumulation and a high risk of life-threatening angioedema. The FDA strictly mandates a 36-hour washout period when switching between these two classes. Since the patient took the last ARNI dose at 8:00 AM today, the earliest safe time to administer lisinopril is exactly 36 hours later, which is 8:00 PM tomorrow.

Step-by-Step Solution

1
Identify the pharmacologic classes involved in the medication transition
The patient is switching from sacubitril-valsartan (an angiotensin receptor-neprilysin inhibitor or ARNI) to lisinopril (an angiotensin-converting enzyme or ACE inhibitor).
Different medication transitions in heart failure management have specific safety protocols based on their mechanisms of action and pharmacokinetic profiles.
2
Recall the safety guidelines regarding overlapping neprilysin and ACE inhibition
Concurrent use of ARNIs and ACE inhibitors is absolutely contraindicated due to a synergistic increase in bradykinin, which can cause life-threatening angioedema.
Both neprilysin and ACE are major enzymes responsible for the degradation of bradykinin. Blocking both pathways simultaneously severely impairs bradykinin clearance.
3
Determine the required medication washout period
A strict 36-hour washout period is required when transitioning from an ARNI to an ACE inhibitor, or from an ACE inhibitor to an ARNI.
This 36-hour interval allows sufficient time for neprilysin clearance and normal bradykinin metabolism to resume before introducing an ACE inhibitor.
4
Calculate the correct initiation time based on the patient's last dose
The last ARNI dose was taken at 8:00 AM today. Adding 36 hours results in an earliest safe initiation time of 8:00 PM tomorrow.
To provide accurate prescribing instructions that maximize safety while avoiding an unnecessarily prolonged gap in neurohormonal blockade.

Key Concept

When transitioning a patient between an angiotensin receptor-neprilysin inhibitor (ARNI) and an ACE inhibitor, a strict 36-hour washout period is required to prevent life-threatening angioedema caused by excessive bradykinin accumulation.
Question 1237Question →

A 58-year-old man with a history of decompensated alcoholic cirrhosis is evaluated in the emergency department for worsening abdominal distension, fever, and confusion over the past 24 hours. His current outpatient medications include propranolol, spironolactone, furosemide, and lactulose. His temperature is 38.1∘C38.1^\circ\text{C} (100.6∘F100.6^\circ\text{F}), blood pressure is 92/58 mmHg92/58\text{ mmHg}, and heart rate is 108/min108/\text{min}. Physical examination reveals a lethargic man with a distended, diffusely tender abdomen, shifting dullness, and mild asterixis. Laboratory studies show:

Laboratory TestResult
Leukocyte count12,500/mm312,500/\text{mm}^3
Total bilirubin4.5 mg/dL4.5\text{ mg/dL}
Blood urea nitrogen38 mg/dL38\text{ mg/dL}
Serum creatinine1.9 mg/dL1.9\text{ mg/dL} (baseline 1.0 mg/dL1.0\text{ mg/dL})

Diagnostic paracentesis yields cloudy fluid with a nucleated cell count of 600/mm3600/\text{mm}^3 and 80%80\% polymorphonuclear leukocytes.

Which of the following pharmacologic interventions are appropriate for this patient's acute management? (Select all that apply.)

Select all that apply

Show answer & explanation

Answer: Initiate intravenous ceftriaxone; Administer intravenous albumin; Discontinue home propranolol

Answer

The appropriate pharmacologic interventions are initiating intravenous ceftriaxone, administering intravenous albumin, and discontinuing home propranolol.
The patient has spontaneous bacterial peritonitis (SBP), diagnosed by an ascitic fluid absolute neutrophil count ≥250/mm3\geq 250/\text{mm}^3 (in this case, 600×0.80=480/mm3600 \times 0.80 = 480/\text{mm}^3). The standard of care includes empiric coverage with a third-generation cephalosporin, such as intravenous ceftriaxone. Because the patient also has acute kidney injury (creatinine >1.0 mg/dL> 1.0\text{ mg/dL}) and significant hyperbilirubinemia, intravenous albumin is strongly indicated to prevent hepatorenal syndrome and reduce mortality. Furthermore, nonselective beta-blockers (like propranolol) should be discontinued in patients with cirrhosis who develop SBP, severe sepsis, or acute kidney injury due to the high risk of hemodynamic collapse.

Step-by-Step Solution

1
Calculate the ascitic fluid absolute neutrophil count (ANC).
The ANC is 480/mm3480/\text{mm}^3 (600×0.80600 \times 0.80), confirming the diagnosis of spontaneous bacterial peritonitis (SBP).
An ANC ≥250/mm3\geq 250/\text{mm}^3 establishes the diagnosis of SBP and warrants immediate empiric treatment.
2
Identify appropriate empiric antimicrobial therapy.
Intravenous ceftriaxone is selected.
Third-generation cephalosporins provide excellent coverage against the most common enteric pathogens responsible for community-acquired SBP.
3
Assess indications for adjunctive intravenous albumin.
Intravenous albumin is indicated.
The patient's elevated serum creatinine (1.9 mg/dL1.9\text{ mg/dL}) and bilirubin (4.5 mg/dL4.5\text{ mg/dL}) meet established criteria for albumin administration to prevent hepatorenal syndrome.
4
Evaluate current outpatient medications for safety in the setting of acute decompensation.
Home propranolol and diuretics (spironolactone, furosemide) must be discontinued.
In the setting of SBP and acute kidney injury, nonselective beta-blockers and diuretics are contraindicated due to the high risk of exacerbating circulatory dysfunction and worsening renal perfusion.

Key Concept

Patients with spontaneous bacterial peritonitis complicated by acute kidney injury require empiric third-generation cephalosporins, intravenous albumin to prevent hepatorenal syndrome, and the immediate discontinuation of antihypertensive and diuretic therapies (e.g., nonselective beta-blockers, spironolactone).
Question 1238Question →

A 24-year-old woman with type 1 diabetes mellitus is admitted to the intensive care unit with diabetic ketoacidosis. Initial laboratory studies show a blood glucose of 520520 mg/dL, an arterial pH of 7.127.12, an anion gap of 2222, and a serum potassium of 2.92.9 mEq/L. Arrange the following steps regarding her ongoing management, monitoring, and therapeutic transition in the correct chronological sequence.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for managing, monitoring, and transitioning therapy in diabetic ketoacidosis with severe hypokalemia is: 1) Initial fluid resuscitation, 2) Potassium replacement while holding insulin, 3) Intravenous insulin initiation, 4) Addition of dextrose to fluids, and 5) Transition to subcutaneous insulin.
The management of diabetic ketoacidosis requires a precise sequence of interventions based on continuous monitoring. First, intravascular volume must be restored with normal saline to improve tissue perfusion. Second, because total body potassium is depleted and insulin drives potassium intracellularly, serum potassium must be corrected to at least 3.3 mEq/L before initiating insulin to prevent fatal arrhythmias. Third, once potassium is safe, continuous intravenous regular insulin is started to suppress ketogenesis and resolve the acidosis. Fourth, because blood glucose typically normalizes faster than the ketoacidosis resolves, 5% dextrose is added to the intravenous fluids when glucose reaches 200-250 mg/dL; this prevents hypoglycemia while allowing the insulin infusion to continue. Finally, once serial monitoring shows a closed anion gap and the patient is tolerating oral intake, therapy is safely de-escalated to a subcutaneous basal-bolus insulin regimen.

Step-by-Step Solution

1
Identify the immediate need for intravascular volume expansion.
Administer 0.9% normal saline.
Patients with DKA have profound osmotic diuresis leading to severe dehydration; restoring perfusion is the priority.
2
Assess the initial serum potassium level prior to insulin administration.
Hold insulin and replace potassium intravenously.
The patient's potassium is critically low at 2.9 mEq/L. Insulin drives potassium intracellularly; giving it now would cause life-threatening hypokalemia.
3
Evaluate potassium status to determine when it is safe to start insulin.
Initiate continuous intravenous regular insulin infusion.
Once potassium is replenished to at least 3.3 mEq/L, insulin is required to halt lipolysis and resolve the anion gap acidosis.
4
Monitor serial blood glucose levels during the continuous insulin infusion.
Add 5% dextrose to the IV fluids.
Glucose falls faster than ketones clear. Dextrose must be added when glucose reaches 200-250 mg/dL to allow continued insulin administration without causing hypoglycemia.
5
Monitor serial basic metabolic panels to evaluate the anion gap.
Transition to a subcutaneous insulin regimen.
Once the anion gap closes (indicating resolution of ketoacidosis) and the patient can tolerate oral intake, intravenous therapy can be safely de-escalated.

Key Concept

Successful management and monitoring of diabetic ketoacidosis requires strict sequential interventions: volume repletion, potassium correction prior to insulin initiation, glucose monitoring to determine dextrose addition, and anion gap monitoring to determine safe transition to subcutaneous insulin.
Question 1239Question →

A 52-year-old man is evaluated on hospital day 18 for worsening fever and abdominal pain. He was initially admitted for severe acute gallstone pancreatitis. Over the first week of his hospitalization, he required aggressive intravenous fluid resuscitation and intensive care monitoring, but his condition had steadily improved until two days ago. Currently, his temperature is 39.4∘C39.4^\circ\text{C} (102.9∘F102.9^\circ\text{F}), blood pressure is 105/65105/65 mm Hg, pulse is 118118/min, and respiratory rate is 2222/min. Physical examination reveals a distended abdomen with marked epigastric tenderness but no rebound or guarding. Laboratory studies show a leukocyte count of 22,000/μL22,000/\mu\text{L}. A contrast-enhanced computed tomography scan of the abdomen demonstrates a 12×1012 \times 10 cm heterogeneous fluid collection replacing the body and tail of the pancreas, containing multiple distinct gas bubbles. Intravenous meropenem is initiated. What is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Percutaneous image-guided catheter drainage

Answer

Percutaneous image-guided catheter drainage
The correct intervention is percutaneous image-guided catheter drainage. This patient has developed infected pancreatic necrosis, diagnosed by clinical deterioration in the third week of severe pancreatitis and the pathognomonic finding of gas within the necrotic collection on a computed tomography scan. The management of infected pancreatic necrosis mandates both broad-spectrum antibiotics (e.g., meropenem) and mechanical source control. The current standard of care utilizes a 'step-up approach.' This strategy begins with minimally invasive drainage, either via percutaneous image-guided catheters or endoscopic transmural drainage. If the patient does not improve with initial drainage, the drains can be upsized, or a video-assisted retroperitoneal debridement (VARD) can be performed. Primary open necrosectomy is avoided due to significantly higher risks of bleeding, fistulas, multiorgan failure, and death.

Step-by-Step Solution

1
Evaluate the patient's clinical trajectory and imaging findings.
The patient has late-onset clinical deterioration (fever, leukocytosis, tachycardia) with a CT scan showing gas within a necrotic pancreatic collection.
Gas within a pancreatic fluid collection in the setting of clinical sepsis is pathognomonic for infected pancreatic necrosis.
2
Determine the necessary therapeutic components for infected necrosis.
Systemic broad-spectrum antibiotics and mechanical source control are both required.
Antibiotics alone cannot adequately penetrate and sterilize large volumes of necrotic, avascular tissue.
3
Select the optimal interventional method for source control.
A minimally invasive 'step-up approach' starting with percutaneous or endoscopic transmural drainage is chosen over primary open surgery.
Clinical trials demonstrate that primary open necrosectomy carries higher rates of multiorgan failure and death, making the step-up approach the standard of care.

Key Concept

The standard of care for infected pancreatic necrosis is a 'step-up approach,' which initiates treatment with minimally invasive percutaneous or endoscopic drainage to achieve source control while minimizing surgical morbidity.
Question 1240Question →

A physician is reviewing the charts of four patients presenting with different manifestations of suspected gastrointestinal blood loss. Match each clinical presentation with the most appropriate next diagnostic test in their evaluation sequence.

Click a left item, then click its matching right item

Items

A hemodynamically stable 68-year-old man with new-onset fatigue, microcytic anemia, and brown stool positive for occult blood.
A 45-year-old woman with a history of cirrhosis presenting with large-volume hematemesis, tachycardia, and a blood pressure of 88/50 mmHg despite crystalloid infusion.
A 72-year-old man with massive hematochezia who remains hypotensive at 80/40 mmHg despite receiving 2 liters of crystalloid and 2 units of packed red blood cells.
A 58-year-old woman with recurrent melena and persistent anemia who had a normal esophagogastroduodenoscopy (EGD) and normal colonoscopy performed 48 hours ago.

Matches

Show answer & explanation

Answer

The presentations map to their respective sequential diagnostic tests as follows: the stable patient with occult blood requires a colonoscopy; the cirrhotic patient with hematemesis requires an urgent EGD; the unstable patient with massive hematochezia requires CT angiography; and the patient with obscure bleeding after negative bidirectional endoscopy requires a video capsule endoscopy.
Each diagnostic test is matched to its strict guideline-indicated clinical scenario. Colonoscopy evaluates occult bleeding; urgent EGD diagnoses and treats variceal hemorrhage; CT angiography localizes rapid bleeding in unstable patients; and video capsule endoscopy evaluates the small bowel after negative initial bidirectional endoscopies.

Step-by-Step Solution

1
Assess the patient's hemodynamic stability.
Stable patients can undergo elective procedures (e.g., outpatient colonoscopy), while unstable patients require immediate, often imaging-based or emergent endoscopic interventions.
Hemodynamic status dictates whether a patient can safely tolerate standard bowel preparation or requires immediate localization of rapid blood loss.
2
Characterize the bleeding source based on clinical signs (e.g., occult vs. overt, upper vs. lower).
Occult blood points toward standard screening (colonoscopy); hematemesis points to an upper source (EGD); massive hematochezia points to an active lower source.
The nature of the bleeding guides the anatomical starting point of the diagnostic sequence.
3
Evaluate the results of prior testing to determine the next tier of the workup.
If standard bidirectional endoscopy (EGD and colonoscopy) is negative but bleeding persists, the small bowel must be investigated.
Diagnostic workup follows a stepwise sequence to prevent premature use of specialized testing (like capsule endoscopy) before ruling out common upper and lower sources.

Key Concept

Diagnostic test sequencing for gastrointestinal bleeding depends strictly on the patient's hemodynamic stability, characteristics of the bleeding (overt versus occult, upper versus lower), and the results of preliminary endoscopic evaluations.
PreviousPage 62 / 104Next
Patient Management Practice Questions — USMLE Step 3 — Page 62 | Examkin